Our COVID-19 news

We are committed to communicating with the public about our COVID-19 research. Our experts engage with the media to provide thought leadership and information you can trust.

Search news

Browse by category

Browse: ▾

Select all - Clear all
Dr Dominic De Nardo is a Group Leader in the Department of Biochemistry & Molecular Biology, Immunity Program within the Monash Biomedicine Discovery Institute.

Cancer drug dampens COVID-related inflammation

A cancer drug could play an important role in limiting the damaging effects of inflammation in COVID-19 patients, thanks to new research co-led by Hudson Institute of Medical Research, Monash University and the Centenary Institute.
19 September, 2023 Biomedicine Discovery Institute

Research reveals how COVID-19 virus infects the placenta, and how this can be prevented

In a landmark study published 14 July in Nature Cell Biology, Australian researchers from Monash University and the University of Adelaide and the Peter Doherty Institute for Infection and Immunity, have revealed how COVID-19 can infect the human
14 July, 2023 Biomedicine Discovery Institute

Funding for mRNA vaccine study could result in universal flu vaccine

With a $100,000 grant from the Victorian Government's mRNA Victoria Research Acceleration Fund Monash CCS and BDI researchers team up to formulate mRNA vaccines and test their efficacy.
23 June, 2023 News

MRFF back Monash mRNA researchers

The Commonwealth Government’s Medical Research Future Fund (MRFF) has invested $5 million into a new Monash laboratory dedicated to developing mRNA vaccines and therapeutics for future clinical trials.
20 March, 2023 Biomedicine Discovery Institute

Victoria’s first mRNA innovation hub backed by state government

A collaborative team of Melbourne researchers from Monash University and the University of Melbourne have received $5.4 million from the Victorian government to establish The Victorian mRNA Innovation Hub to develop next-generation mRNA vaccines and
9 August, 2022 Biomedicine Discovery Institute

NUS-Monash University collaboration produces universal flu vaccine candidate

Influenza, commonly referred to as “flu”, is a major global public health concern and a huge economic burden to societies.
28 March, 2022 Biomedicine Discovery Institute
Dr Gavin Knott, Snow Fellowship recipient

Monash researcher receives $8m Snow Medical Foundation Fellowship to ‘unlock nature’s toolbox’ for RNA biomedicine

Leading the Knott Lab at Monash’s Biomedicine Discovery Institute, Dr Knott is one of only three researchers in Australia to receive the $8 million, eight-year fellowship to develop Australia’s next generation of biomedical research
4 March, 2022 Biomedicine Discovery Institute

Monash University update on Ivermectin trial

As indicated in our August statement on the Monash BDI news page, Dr Kylie Wagstaff has been working to establish a blinded and randomised clinical trial of Ivermectin.
2 March, 2022 Biomedicine Discovery Institute
Image: Green pin located over the map of Melbourne

Monash Uni stakes its claim for Moderna’s mRNA facility

Despite strong competition, Victoria has encouraged Moderna to come to its state. With the location of it’s manufacturing site looking to be confirmed by the end of April, our RNA experts provide insights into just how important choosing the
18 February, 2022 News